跳至主要内容
临床试验/NL-OMON51509
NL-OMON51509尚未招募不适用

Eye-tracking parameters as biomarkers of frontotemporal dementia - Eye-tracking in FTD (FTDEYE)

eurologie0 个研究点目标入组 136 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
136

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1) Patients with FTD referred to our referral center and diagnosed with use of
  • International
  • Consensus Criteria. The dementia symptoms have to be mild (clinical dementia
  • rating <=1). Patients with all variants of FTD (behavioural frontotemporal
  • dementia, semantic variant PPA, non-fluent variant PPA) will be included.
  • 2) Patients with mild Alzheimer's dementia diagnosed according to International
  • Consensus Criteria. The dementia has to be mild (clinical dementia rating <=1).
  • 3) Asymptomatic, first degree relatives of dementia patients due to genetic
  • mutations. They have 50% chance of having the mutation and developing FTD. DNA
  • status is determined in a related study (MEC-2009-409) in a double-blind
  • design. Participation is possible from 18 years and over.

排除标准

  • Subjects with a previous stroke or other (neurological) conditions that may
  • affect cognitive functions (brain tumour, multiple sclerosis, use of
  • psycho-active medications) will be excluded from participation in this study.

研究者

发起方
eurologie

相似试验